Chad D. Ehrenkranz is a corporate partner in the New York office of Kirkland & Ellis LLP. Chad’s focus is on healthcare transactional, regulatory and enforcement matters, frequently on behalf of private equity sponsors and their portfolio companies. He regularly represents healthcare clients in structuring and negotiating mergers, acquisitions, joint ventures, affiliations, compliance matters and investigations, employment and consulting arrangements, and contractual, corporate, regulatory, real estate and risk management healthcare legal issues.
Chad regularly counsels clients on the corporate practice of medicine and professionals, state and federal fraud and abuse laws, which includes but is not limited to, Stark Law, Anti-Kickback Statute, False Claims Act, state anti-referral and anti-kickback laws and related regulatory issues. Chad is experienced in federal and state healthcare regulatory and licensure, enrollment and reimbursement matters. Chad also provides healthcare regulatory guidance to numerous insurers. Chad actively represents clients on a national and international basis.
Chad was recognized in Chambers USA for his transactional work in Healthcare, where clients commented "[Chad] is very intellectually sharp; in really complex issues, he drills down to the problem." In the 2022 edition of Chambers USA, clients noted, "Chad is fabulous. He is extremely knowledgeable, knows the industry and is always there to help.”
Thursday August 25, 2022
Liability in Healthcare Fraud & Abuse: Considerations for PE Sponsors and Their Portfolios
- Overview of the False Claims Act
- Recent enforcement actions involving owners and operators
- Adopting compliance programs and the role of independent audits